Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이지수 | - |
dc.date.accessioned | 2018-12-07T16:31:00Z | - |
dc.date.available | 2018-12-07T16:31:00Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 1756-1841 | - |
dc.identifier.issn | 1756-185X | - |
dc.identifier.other | OAK-14397 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/247501 | - |
dc.description.abstract | Aim: To evaluate treatment patterns and clinical factors affecting gout flare in South Korea. Methods: We retrospectively examined data from 401 patients seen at nine rheumatology multicenter clinics, under urate lowering therapy (ULT) more than 6 months after stopping prophylactic medication. Demographic data, clinical and laboratory features were collected at the initiation of ULT, upon stopping prophylaxis, and 6 months after. Results: The mean age was 52.2 years and mean disease duration was 25.0 months. The male-to-female count was 387 : 14. The most common ULT starting agent was allopurinol 83.8%. Colchicine (62.3%) was the most commonly prescribed prophylactic agent. During ULT, 134 of the 401 patients (33.4%) experienced at least one gouty attack in the period from stopping prophylaxis to 6 months later. The duration of prophylaxis was different between those with serum uric acid levels below 6 mg/dL and those over 6 mg/dL (P = 0.001). Of the 179 patients (44.6%) who attained target serum uric acid (SUA) levels (6 mg/dL) at the end of prophylaxis, those taking < 6 months of prophylaxis suffered more frequent flares than those taking it >= 6 months (42.9% vs. 26.3%, P = 0.041). The time interval to the first attack after stopping prophylaxis was shorter in the < 6 months group than the >= 6 months group (13.5 weeks vs. 22.5 weeks, P = 0.007). Conclusions: Prophylaxis more than 6 months from initiation of ULT, and achieving target SUA (< 6 mg/dL) at the time of stopping prophylaxis is associated with fewer gout flares during ULT. | - |
dc.language | English | - |
dc.publisher | WILEY | - |
dc.subject | flare | - |
dc.subject | gout treatment | - |
dc.subject | prophylactic duration | - |
dc.subject | serum uric acid | - |
dc.title | Current gout treatment and flare in South Korea: Prophylactic duration associated with fewer gout flares | - |
dc.type | Article | - |
dc.relation.issue | 4 | - |
dc.relation.volume | 20 | - |
dc.relation.index | SCIE | - |
dc.relation.index | SCOPUS | - |
dc.relation.startpage | 497 | - |
dc.relation.lastpage | 503 | - |
dc.relation.journaltitle | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | - |
dc.identifier.doi | 10.1111/1756-185X.12422 | - |
dc.identifier.wosid | WOS:000405267300012 | - |
dc.identifier.scopusid | 2-s2.0-85028281849 | - |
dc.author.google | Choi, Hyo Jin | - |
dc.author.google | Lee, Chan Hee | - |
dc.author.google | Lee, Joo Hyun | - |
dc.author.google | Yoon, Bo Young | - |
dc.author.google | Kim, Hyoun Ah | - |
dc.author.google | Suh, Chang Hee | - |
dc.author.google | Choi, Sang Tae | - |
dc.author.google | Song, Jung Soo | - |
dc.author.google | Joo, Ho Yeon | - |
dc.author.google | Choi, Sung Jae | - |
dc.author.google | Lee, Ji Soo | - |
dc.author.google | Shin, Kee Chul | - |
dc.author.google | Baek, Han Joo | - |
dc.contributor.scopusid | 이지수(14424388700) | - |
dc.date.modifydate | 20230201112642 | - |